Skye Bioscience Inc.

NASDAQ: SKYE · Real-Time Price · USD
3.53
0.26 (7.95%)
At close: Aug 15, 2025, 3:59 PM
3.51
-0.57%
After-hours: Aug 15, 2025, 07:36 PM EDT

Skye Bioscience Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a 163.39K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
187.07K 177.38K 175.29K 66K 29.79K 27.56K 28.37K 28.79K 33.92K 33.17K 31.53K 28.8K 27.68K n/a 24.72K n/a n/a n/a
Gross Profit
-187.07K -177.38K -175.29K -66K -29.79K -27.56K -28.37K -28.79K -33.92K -33.17K -31.53K -28.8K -27.68K n/a n/a n/a n/a n/a
Operating Income
-18.24M -11.76M -10.67M -9.52M -8.41M -6.15M -4.09M -24.71M -3M -3.1M -3.08M -2.92M -3.22M -2.89M -2.46M -1.82M -1.83M -1.74M
Interest Income
533.09K 619.05K 732.27K 1.29M 961.24K 426.51K 50.3K 16.56K 8.6K 24.51K 19.01K n/a n/a n/a 3.00 n/a n/a n/a
Pretax Income
-17.62M -11.1M -9.75M -3.9M -7.89M -5.02M -4.42M -24.95M -3.11M -5.17M -9.89M -3.13M -3.41M -3.04M -2.51M -1.82M -2.02M -2.16M
Net Income
-17.62M -11.1M -9.75M -3.9M -7.9M -5.02M -4.42M -24.95M -3.11M -5.17M -9.89M -3.13M -3.42M -3.04M -2.51M -1.82M -2.02M -2.16M
Selling & General & Admin
3.91M 4.56M 4.55M 4.64M 4.33M 4.21M 2.5M 2.24M 1.21M 1.92M 1.54M 1.14M 1.79M 1.62M 1.35M 1.49M 949K 1.13M
Research & Development
14.34M 7.2M 7.79M 4.88M 4.08M 1.95M 1.59M 1.25M 1.79M 1.19M 1.54M 1.78M 1.43M 1.27M 1.11M 327.73K 880.67K 609.66K
Other Expenses
n/a 1K -1.68M -4.55M n/a n/a n/a 21.21M 209.44K n/a 6.21M n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
18.24M 11.76M 10.67M 4.97M 8.41M 6.15M 4.09M 24.71M 2.84M 3.1M 9.28M 2.92M 3.22M 2.89M 2.44M 1.82M 1.83M 1.74M
Interest Expense
n/a 1.45K -428.75K 291.07K 450.05K 436.94K 430.13K 271.31K 186.43K 18.4K 169.8K 211.23K 205.3K 199.03K 198.84K 195.36K 190.06K 184.91K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
18.24M 11.76M 10.67M 4.97M 8.41M 6.15M 4.09M 24.71M 2.84M 3.1M 9.28M 2.92M 3.22M 2.89M 2.46M 1.82M 1.83M 1.74M
Income Tax Expense
3.4K 2K n/a n/a 8.07K 2K n/a n/a 3.6K n/a 1.6K n/a 5.14K n/a 500.00 n/a 1.6K n/a
Shares Outstanding (Basic)
39.66M 39.65M 39.97M 38.82M 38.67M 28M 12.35M 7.88M 3.89M 3.77M 2.51M 1.98M 1.98M 1.98M 1.64M 1.65M 1.51M 1.35M
Shares Outstanding (Diluted)
39.66M 39.65M 39.97M 38.82M 38.67M 28M 12.35M 7.88M 3.89M 3.77M 2.51M 1.98M 1.98M 1.98M 1.66M 1.66M 1.51M 1.35M
EPS (Basic)
-0.44 -0.28 -0.24 -0.1 -0.2 -0.18 -0.36 -3.17 -0.8 -1.37 -4.99 -1.58 -1.72 -1.61 -1.53 -1.1 -2.5 -1.6
EPS (Diluted)
-0.44 -0.28 -0.24 -0.1 -0.2 -0.18 -0.36 -3.17 -0.8 -1.37 -4.99 -1.58 -1.72 -1.61 -1.52 -1.1 -2.5 -1.6
EBITDA
-17.43M -10.92M -9.62M -3.54M -7.42M -4.55M -3.97M -24.62M -2.89M -5.12M -9.81M -2.89M -3.18M -2.82M -2.29M -1.62M -1.83M -1.98M
EBIT
-17.62M -11.1M -9.79M -3.9M -7.45M -4.58M -4M -24.65M -2.92M -5.15M -9.84M -2.92M -3.21M -2.85M -2.31M -1.63M -1.83M -1.98M
Depreciation & Amortization
187.07K 177.38K 175.29K 66K 29.79K 27.56K 28.37K 28.79K 33.92K 33.17K 31.53K 28.8K 27.68K 26.98K 24.72K 7.46K 1.01K 938.00